Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02007200Phase 2Completed
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+28 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Chandylen Nightingale

Wake Forest University Health Sciences

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+16 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Eric Winquist

University Health Network Princess Margaret Cancer Center P2C

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Tanguy Seiwert

University of Chicago Comprehensive Cancer Center P2C

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Nabil F. Saba, MD

Emory University/Winship Cancer Institute

Related
1 trials

Shared therapeutic areas:

Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+8 more
Similarity Score11%

Shlomo Koyfman

Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Stage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell Carcinoma+4 more
Similarity Score7%

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Hassan Arshad

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Eric Chen

University Health Network-Princess Margaret Hospital

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Daniel Ma

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Stage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell Carcinoma+1 more
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02007200Phase 2PrincipalInvestigator

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+28 more
Completed

All 1 trials loaded